UroGen Pharma (URGN) Cash & Current Investments (2016 - 2026)
UroGen Pharma's Cash & Current Investments came in at $107.98 million for Q2 2026, down 31.2% from $156.95 million a year earlier and down 23.0% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Cash & Current Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Cash & Current Investments was $120.46 million, down 49.1% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $236.69 million in FY2024 (+72.8%), $136.97 million in FY2023 (+37.0%), $99.96 million in FY2022 (+12.1%) and $89.14 million in FY2021 (-12.6%).
- The Q2 2026 figure represents the lowest quarterly Cash & Current Investments since Q2 2023.
- Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 3.9% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2024 (growth of 409.7%), and the weakest in Q2 2023 (a decline of 57.7%).
- Business Quant data shows URGN's Cash & Current Investments at $140.27 million (Q1 2026), $120.46 million (Q4 2025) and $127.03 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn | 107.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.98 Mn |
| Mar 31, 2026 | 140.27 Mn |
| Dec 31, 2025 | 120.46 Mn |
| Sep 30, 2025 | 127.03 Mn |
| Jun 30, 2025 | 156.95 Mn |
| Mar 31, 2025 | 195.89 Mn |
| Dec 31, 2024 | 236.69 Mn |
| Sep 30, 2024 | 249.58 Mn |
| Jun 30, 2024 | 241.08 Mn |
| Mar 31, 2024 | 164.05 Mn |
| Dec 31, 2023 | 136.97 Mn |
| Sep 30, 2023 | 147.42 Mn |
| Jun 30, 2023 | 47.30 Mn |
| Mar 31, 2023 | 65.05 Mn |
| Dec 31, 2022 | 99.96 Mn |
| Sep 30, 2022 | 95.91 Mn |
| Jun 30, 2022 | 111.74 Mn |
| Mar 31, 2022 | 136.44 Mn |
| Dec 31, 2021 | 89.14 Mn |
| Sep 30, 2021 | 106.21 Mn |
API Access
UroGen Pharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();